
ARCT Valuation
Arcturus Therapeutics Holdings Inc
- Overview
- Forecast
- Valuation
- Earnings
ARCT Relative Valuation
ARCT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ARCT is overvalued; if below, it's undervalued.
Historical Valuation
Arcturus Therapeutics Holdings Inc (ARCT) is now in the Fair zone, suggesting that its current forward PS ratio of 5.11 is considered Fairly compared with the five-year average of -10.39. The fair price of Arcturus Therapeutics Holdings Inc (ARCT) is between 10.25 to 15.18 according to relative valuation methord.
Relative Value
Fair Zone
10.25-15.18
Current Price:14.53
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.60
P/B
Median3y
2.37
Median5y
3.21
-24.55
FCF Yield
Median3y
-7.19
Median5y
-9.02
Competitors Valuation Multiple
The average P/S ratio for ARCT's competitors is 8.97, providing a benchmark for relative valuation. Arcturus Therapeutics Holdings Inc Corp (ARCT) exhibits a P/S ratio of 5.11, which is -43.02% above the industry average. Given its robust revenue growth of -22.70%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch

TWFG
TWFG Inc
32.220
USD
+0.09%

SWBI
Smith & Wesson Brands Inc
8.260
USD
+4.69%

MITK
Mitek Systems Inc
9.360
USD
-0.85%

TCBX
Third Coast Bancshares Inc
35.800
USD
-0.67%

CDXC
Chromadex Corp
7.920
USD
-0.89%

GCO
Genesco Inc
24.490
USD
+4.57%

ANSC
Agriculture & Natural Solutions Acquisition Corp
10.880
USD
+0.05%

BH
Biglari Holdings Inc
322.640
USD
+2.13%

AKBA
Akebia Therapeutics Inc
3.850
USD
+0.26%

KELYA
Kelly Services Inc
13.220
USD
+4.01%
FAQ

Is Arcturus Therapeutics Holdings Inc (ARCT) currently overvalued or undervalued?
Arcturus Therapeutics Holdings Inc (ARCT) is now in the Fair zone, suggesting that its current forward PS ratio of 5.11 is considered Fairly compared with the five-year average of -10.39. The fair price of Arcturus Therapeutics Holdings Inc (ARCT) is between 10.25 to 15.18 according to relative valuation methord.

What is Arcturus Therapeutics Holdings Inc (ARCT) fair value?

How does ARCT's valuation metrics compare to the industry average?

What is the current P/B ratio for Arcturus Therapeutics Holdings Inc (ARCT) as of Jul 23 2025?

What is the current FCF Yield for Arcturus Therapeutics Holdings Inc (ARCT) as of Jul 23 2025?

What is the current Forward P/E ratio for Arcturus Therapeutics Holdings Inc (ARCT) as of Jul 23 2025?
